Next Article in Journal
Effects of Onion (Allium cepa L.) Extract Administration on Intestinal α-Glucosidases Activities and Spikes in Postprandial Blood Glucose Levels in SD Rats Model
Next Article in Special Issue
Systematic Approaches towards the Development of Host-Directed Antiviral Therapeutics
Previous Article in Journal
Recent Advances in Plant Early Signaling in Response to Herbivory
Previous Article in Special Issue
Multi-Step Usage of in Vivo Models During Rational Drug Design and Discovery
Article Menu

Export Article

Open AccessArticle
Int. J. Mol. Sci. 2011, 12(6), 3740-3756;

Sulfotyrosine Recognition as Marker for Druggable Sites in the Extracellular Space

Department of Biochemistry, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, WI 53226, USA
Department of Chemistry, University of Wisconsin-Whitewater, 800 West Main Street, Whitewater, WI 53190, USA
Author to whom correspondence should be addressed.
Received: 14 March 2011 / Revised: 16 May 2011 / Accepted: 23 May 2011 / Published: 8 June 2011
(This article belongs to the Special Issue A Systematic Development Method for Rational Drug Design)
Full-Text   |   PDF [787 KB, uploaded 19 June 2014]


Chemokine signaling is a well-known agent of autoimmune disease, HIV infection, and cancer. Drug discovery efforts for these signaling molecules have focused on developing inhibitors targeting their associated G protein-coupled receptors. Recently, we used a structure-based approach directed at the sulfotyrosine-binding pocket of the chemokine CXCL12, and thereby demonstrated that small molecule inhibitors acting upon the chemokine ligand form an alternative therapeutic avenue. Although the 50 members of the chemokine family share varying degrees of sequence homology (some as little as 20%), all members retain the canonical chemokine fold. Here we show that an equivalent sulfotyrosine-binding pocket appears to be conserved across the chemokine superfamily. We monitored sulfotyrosine binding to four representative chemokines by NMR. The results suggest that most chemokines harbor a sulfotyrosine recognition site analogous to the cleft on CXCL12 that binds sulfotyrosine 21 of the receptor CXCR4. Rational drug discovery efforts targeting these sites may be useful in the development of specific as well as broad-spectrum chemokine inhibitors. View Full-Text
Keywords: chemokine; sulfotyrosine, NMR; structure; alignment; drug discovery chemokine; sulfotyrosine, NMR; structure; alignment; drug discovery
This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Share & Cite This Article

MDPI and ACS Style

Ziarek, J.J.; Heroux, M.S.; Veldkamp, C.T.; Peterson, F.C.; Volkman, B.F. Sulfotyrosine Recognition as Marker for Druggable Sites in the Extracellular Space. Int. J. Mol. Sci. 2011, 12, 3740-3756.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top